Published
A Review on Multi-layered Tablets: A way to control the drug release
, , ,
Published in January 2023 Issue 1 (Vol. 11, Issue 1, 2023)

Abstract
ABSTRACTDue to necessities their affordable manufacturing costs and simplicity of administration, especially in controlled-release applications, tablet dosage forms have traditionally been chosen over other formulations for oral medication delivery. Over monotherapy, combination therapy has a number of benefits. The pharmaceutical industry has grown more interested in recent years in creating dosage forms (monolithic, bilayer, or multi-layered tablets) that combine two or more Active Pharmaceutical Ingredients (API), improving patient convenience and compliance. The active pharmaceutical ingredient (API) is delivered from controlled-release tablets over an intended or prolonged period of time after oral administration. This may allow for a reduction in peak plasma concentrations and dose frequency, which enhances patient compliance while lowering the likelihood of unfavorable side effects. To transfer APIs into the body, conventional single-layered matrix tablets have been widely used. These traditional single-layered matrix tablets, however, have less than ideal delivery characteristics, such as non-linear drug release profiles that could result in more side effects. A multi-layered technology has recently been created to expand upon or replace the single-layered tablet's constraints. With the use of this technology, pharmaceutical businesses may have a better chance of creating new medications and improving their life cycle management. An overview of multi-layered tablets is provided in this article, with particular attention paid to manufacturing challenges, different tablet designs, and drug release profiles. This article covers the necessity for quality Multi-layered Tablet development and production, as well as the present state of the market. Keywords: Multi-layered Tablet, controlled-release tablets, monolithic, matrix tablets
Citations & discovery
Explore citations to this article and find it in scholarly databases.
Checking citation sources…
Citation counts reflect each source's coverage. Europe PMC shows DOI search matches, including mentions in references. Article lists may be incomplete. Google Scholar opens a separate search.
Authors (4)
Sadhana Shahi
View all publications →Manoj B. Barkate
View all publications →Nikita A. Shete
View all publications →Manjari N. Bobade
View all publications →Download Article
Summarise this paper with AI:
Article Information
Published in:
January 2023 Issue 1 (Vol. 11, Issue 1, 2023)Article Impact
Views:1,254
Downloads:2,493
scite_
Smart Citations
0Citing Publications
0Supporting
0Mentioning
0Contrasting
View Citations
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
How to Cite
Shahi, S., Barkate, M. B., Shete, N. A., & Bobade, M. N. (2023). A Review on Multi-layered Tablets: A way to control the drug release. American Journal of Pharmacy and Health Research, 11(1), 1-18. https://doi.org/10.5281/zenodo.7807820
Article Actions
More from this Issue
Orphan Drugs: Advances in the Treatment of Rare Diseases
Sadhana R. Shahi, Anil Ba...Read more →
More by These Authors
Urinary tract infections in Maiduguri-city, Nigeria: a 2005-2009 clinical survey of Fluoroquinolones Activities against Staphylococcus Aureus acting as second most isolated Etiological Pathogens.
2013 • Vol. 1, Issue 6
Read more →
